Treatment of patients hospitalized for psoriasis

scientific article

Treatment of patients hospitalized for psoriasis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1016/S0733-8635(05)70191-1
P698PubMed publication ID10943538

P2093author name stringTaylor JR
Kirsner RS
Prodanovich S
P2860cites workEffects of antipsoriasis drugs and metabolic inhibitors on the growth of epidermal cells in cultureQ28331347
A double-blind evaluation of topical capsaicin in pruritic psoriasisQ34306527
Palmoplantar pustulosis and smokingQ34487048
Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex proteinQ37378121
Effects of cyclosporine on immunologic mechanisms in psoriasis.Q38024550
Histocompatibility antigens: a laboratory and epidemiologic toolQ39869703
Anthralin: historical and current perspectivesQ40136792
White paper on hospitalization for psoriasis careQ40178223
Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens?Q40507210
Immunointervention in psoriasis with anti-CD4 antibodiesQ40624548
A Topical Treatment Program for Psoriasis with Low Anthralin ConcentrationsQ40859077
Treatment settingsQ40881609
Recent advances in the treatment of psoriasisQ40915788
Triggering factorsQ41603184
DithranolQ41603208
Superantigen implicated in dependence of HIV-1 replication in T cells on TCR V beta expressionQ41613389
The Effect of Coal Tar Distillate, Cadmium Sulfide, Ichthyol Sodium and Omadine MDS on the Epidermis of the Guinea PigQ42441438
Altered cell-mediated immunity to group A haemolytic streptococcal antigens in chronic plaque psoriasisQ43697660
Group A streptococcal antigen-specific T lymphocytes in guttate psoriatic lesionsQ70742341
The atrophogenic effect of crude coal tar on human epidermisQ70864620
Effects of anthralin and analogues on growth and [3H] thymidine incorporation in human skin fibroblastsQ70935886
Ingram method: the precursor of photochemotherapyQ70935911
Efficacy and pharmacokinetics of two formulations of cyclosporine A in patients with psoriasisQ71483217
Localization of transforming growth factor-alpha RNA and protein in the skin of psoriatic patients receiving therapyQ71636187
Physicochemical properties and stability of anthralin in model systems and human skinQ71728284
Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basisQ71803269
Onset of psoriasis at age 108Q71830582
A Case of AIDS Manifesting Pruritic Papular Eruptions and Psoriasiform Lesions: An Immunohistochemical Study of the Lesional Dermal InfiltratesQ71997344
Generalized pustular psoriasisQ72414254
Methotrexate in childhood psoriasisQ72833892
Ingram method of treating psoriasisQ77650067
The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseasesQ78173697
Photosensitivity due to pitchQ78830030
Psoriasis of early and late onset: characterization of two types of psoriasis vulgarisQ93634109
Pustulosis palmaris et plantarisQ93746916
Cross-reactivity between streptococcal M surface antigen and human skinQ43835832
HL-A in psoriasis vulgaris and in pustular psoriasis--population and family studiesQ44697150
CD4 antibody treatment of severe psoriasisQ44956410
Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter's syndrome: a disease continuum?Q45850101
Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.Q51008269
Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population- and family-based study.Q53007194
An open prospective clinical trial with systemic ranitidine in the treatment of psoriasis.Q54048097
The approach to psoriasis.Q55688626
Psoriasis und pustulöses ExanthemQ60361483
GENERALIZED PUSTULAR PSORIASISQ61160680
Interferon Gamma-Treated Keratinocytes Activate T Cells in the Presence of Superantigens: Involvement of Major Histocompatibility Complex Class II MoleculesQ61811292
Psoriasis-an index of disabilityQ61890897
Tar Phototoxicity and Phototherapy for PsoriasisQ66918301
Research needs in 11 major areas in dermatology. I. PsoriasisQ66962102
Controlled study of PUVA and adjunctive topical therapy in the management of psoriasisQ67286568
HLA antigens in persistent palmoplantar pustulosis and its relationship to psoriasisQ67402360
HLA B13, B17, B37 and Cw6 in psoriasis vulgaris: association with the age of onsetQ67414569
Corticosteroids and pustular psoriasisQ67448414
Relapse rate of psoriasis worsened by adding steroids to a dithranol regimeQ67499474
The Role of Streptococcal Infection in the Initiation of Guttate PsoriasisQ67752966
The antipsoriatic drug, anthralin, inhibits protein kinase C--implications for its mechanism of actionQ68016658
Acquired immunodeficiency syndrome (AIDS) can exacerbate psoriasisQ68275798
Anthralin-Corticosteroid Combination Therapy in the Treatment of Chronic Plaque PsoriasisQ68306724
Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasisQ68308061
Letter: HL-A histocompatibility and cadaver kidney-graft survivalQ68533800
Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 casesQ68589919
Staphylococcus aureus in the lesions of atopic dermatitisQ69352091
Antirespiratory and antiproliferative activity of anthralin in cultured human keratinocytesQ69380760
Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndromeQ69463241
Class II MHC molecules are specific receptors for staphylococcus enterotoxin AQ69504948
HL-A antigen in psoriasisQ69507842
Proliferative responses of peripheral blood mononuclear cells from psoriatic patients to T lymphocyte-stimulating cytokines (IL-2, IL-3, IL-4, and granulocyte-macrophage colony-stimulating factor) and OK-432Q69547898
Topical Antipsoriatic Agents and Epidermal Mitosis in ManQ69570059
Psoriasis: improvement during and worsening after pregnancyQ69626335
Oligaemia, Renal Failure, and Jaundice Associated with Acute Pustular PsoriasisQ69782375
Experimental contribution to the dithranol-brown problemQ70082947
The T4 lymphocyte in AIDSQ70106967
Hospital treatment of psoriasis. A modified anthralin programQ70133887
Response to injury of skin involved and uninvolved with psoriasis, and its relation to disease activity: Koebner and 'reverse' Koebner reactionsQ70217937
Severe osteolytic arthritis mutilans in pustular psoriasisQ70391669
Histocompatibility (HL-A) Antigens Associated with PsoriasisQ70444528
Disturbance of HL-A Antigen Frequency in PsoriasisQ70444532
Palmoplantar pustular psoriasis provoked by lithium therapyQ70515970
Successful treatment of generalized pustular psoriasis (von Zumbusch) by systemic antibiotics controlled by blood cultureQ70580310
The mode of inheritance of psoriasis: evidence for a major gene as well as a multifactorial component and its implication for genetic counsellingQ70673776
Scale prophylaxis. A new antiparakeratotic assayQ70717698
P433issue3
P921main subjecthospitalizationQ3140971
P304page(s)425-35, viii
P577publication date2000-07-01
P1433published inDermatologic ClinicsQ15758379
P1476titleTreatment of patients hospitalized for psoriasis
P478volume18

Reverse relations

cites work (P2860)
Q33806651Cardiovascular morbidity and mortality in rheumatoid arthritis
Q53312205Pathogenesis of psoriasis and current challenges.
Q46527693Topical preparations for the treatment of psoriasis: results of a retrospective study over 15 years.

Search more.